Indication

Tinea versicolor

Tinea versicolor, also known as pityriasis versicolor, is a common, non-contagious, superficial fungal infection of the stratum corneum caused by an overgrowth of lipid-dependent *Malassezia* yeast species. Read more about Tinea versicolor

451 drugs 143 manufacturers

Advertisement

Drugs that treat it

Common Tinea versicolor therapies.

Showing 334–342 of 451 drugs

CLOTRIMAZOLE

TOPICAL ANTIFUNGALS·TINEA CRURIS·+5
Kaiser Foundation Hospitals
Filter & compare in the drug finder →Opens the drug finder with Tinea versicolor preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Tinea versicolor.

Tinea versicolor, also known as pityriasis versicolor, is a common, non-contagious, superficial fungal infection of the stratum corneum caused by an overgrowth of lipid-dependent *Malassezia* yeast species.

It primarily affects adolescents and young adults, presenting most frequently in sebum-rich areas of the integumentary system such as the trunk, neck, and proximal upper extremities.

Pathophysiologically, the transition of commensal yeast into a dimorphic mycelial form disrupts epidermal melanogenesis, resulting in the condition's hallmark well-demarcated, finely scaling macules or patches that vary in color from hypopigmented to hyperpigmented or erythematous.

Personalize your experience

Follow Tinea versicolor and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it